Safety and Efficacy of Cryoballoon Pulmonary Vein Isolation and Left Atrial Appendage Closure Combined Procedure and Half-Dose Rivaroxaban After Operation in Elderly Patients with Atrial Fibrillation

References

• Orhan AL, Çınar T, Hayıroğlu Mİ, et al. Atrial fibrillation as a preoperative risk factor predicts long-term mortality in elderly patients without heart failure and undergoing Hip fracture surgery. Rev Assoc Med Bras. 2021;67(11):1633–1638. doi:10.1590/1806-9282.20210686
   PubMed Web of Science ®Google Scholar
• Kornej J, Börschel CS, Benjamin EJ, et al. Epidemiology of Atrial Fibrillation in the 21st Century: novel Methods and New Insights. Circ Res. 2020;127(1):e4–e20. doi:10.1161/CIRCRESAHA.120.316340
   PubMed Web of Science ®Google Scholar
• Xiang W, Zhang J, Liu M, et al. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study. Clin Interv Aging. 2015;10:e515–e519. doi:10.2147/CIA.S67974
   PubMed Web of Science ®Google Scholar
• Di Carlo A, Bellino L, Consoli D, et al. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019;21(10):e1468–e1475. doi:10.1093/europace/euz141
   PubMed Web of Science ®Google Scholar
• Alonso A, Norby FL. Predicting atrial fibrillation and its complications. Circ J. 2016;80(5):e1061–e1066. doi:10.1253/circj.CJ-16-0239
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):e2893–e2962. doi:10.1093/eurheartj/ehw210
   PubMed Web of Science ®Google Scholar
• Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374:e2235–e2245. doi:10.1056/NEJMoa1602014
   PubMed Web of Science ®Google Scholar
• Landolina M, Arena G, Iacopino S, et al. Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: data on 860 patients from the real-world multicenter observational project. Int J Cardiol. 2018;272:e130–e136. doi:10.1016/j.ijcard.2018.07.051
   PubMed Web of Science ®Google Scholar
• Lyaker MR, Tulman DB, Dimitrova GT, et al. Arterial embolism. Int J Crit Illn Inj Sci. 2013;3:e77. doi:10.4103/2229-5151.109429
   PubMedGoogle Scholar
• Casu G, Gulizia MM, Molon G, et al. ANMCO/AIAC/SICI-GISE/SIC/SICCH consensus document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training. Eur Heart J Suppl. 2017;19(suppl_D):e333–e353. doi:10.1093/eurheartj/sux008
   Web of Science ®Google Scholar
• Jain AK, Gallagher S. Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance. Heart. 2011;97(9):e762–e765. doi:10.1136/hrt.2010.208223
   PubMed Web of Science ®Google Scholar
• Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. Europace. 2020;22:e184. doi:10.1093/europace/euz258
   PubMed Web of Science ®Google Scholar
• Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):e1–e12. doi:10.1016/j.jacc.2014.04.029
   PubMed Web of Science ®Google Scholar
• Swaans MJ, Post MC, Rensing BJ, et al. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012;1:e002212. doi:10.1161/JAHA.112.002212
   PubMed Web of Science ®Google Scholar
• Phillips KP, Pokushalov E, Romanov A, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace. 2018;20(6):e949–e955. doi:10.1093/europace/eux183
   PubMed Web of Science ®Google Scholar
• Ren Z, Zhang J, Zhu M, et al. Cryoablation Combined with Left Atrial Appendage Closure: a Safe and Effective Procedure for Paroxysmal Atrial Fibrillation Patients. Cardiol Res Pract. 2020;2020:6573296. doi:10.1155/2020/6573296
   PubMed Web of Science ®Google Scholar
• Ren Z, Zhang J, Wang S, et al. Two-Year Outcome From Combining Cryoballoon Ablation and Left Atrial Appendage Closure: CLACBAC Study. Front Cardiovasc Med. 2020;7:610537. doi:10.3389/fcvm.2020.610537
   PubMed Web of Science ®Google Scholar
• Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. doi:10.1093/europace/eux274
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:e104–e132.
   PubMed Web of Science ®Google Scholar
• Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:e755–e759. doi:10.1016/0003-4975(95)00887-X
   PubMed Web of Science ®Google Scholar
• Chen X, Xia Y, Lin Y, et al. Cryoballoon Ablation for Treatment of Atrial Fibrillation in a Chinese Population: five-Year Outcomes and Predictors of Recurrence After a Single Procedure. Front Cardiovasc Med. 2022;9:836392. doi:10.3389/fcvm.2022.836392
   PubMed Web of Science ®Google Scholar
• Su F, Gao C, Liu J, et al. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China. JAMA Netw Open. 2022;5(5):e2214594. doi:10.1001/jamanetworkopen.2022.14594
   PubMed Web of Science ®Google Scholar
• Akhtar T, Berger R, Marine JE, et al. Cryoballoon Ablation of Atrial Fibrillation in Octogenarians. Arrhythm Electrophysiol Rev. 2020;9:e104–e107. doi:10.15420/aer.2020.18
   PubMed Web of Science ®Google Scholar
• Kanda T, Masuda M, Kurata N, et al. Efficacy and safety of the cryoballoon-based atrial fibrillation ablation in patients aged ≥80 years. J Cardiovasc Electrophysiol. 2019;30(11):e2242–e2247. doi:10.1111/jce.14166
   PubMed Web of Science ®Google Scholar
• Osmancik P, Herman D, Neuzil P, et al. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2022;79(1):e1–e14. doi:10.1016/j.jacc.2021.10.023
   PubMed Web of Science ®Google Scholar
• Freixa X, Schmidt B, Mazzone P, et al. Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational Study. Europace. 2021;23(2):e238–e246. doi:10.1093/europace/euaa262
   PubMed Web of Science ®Google Scholar
• Fauchier L, Cinaud A, Brigadeau F, et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. J Am Coll Cardiol. 2018;71:e1528–e1536. doi:10.1016/j.jacc.2018.01.076
   PubMed Web of Science ®Google Scholar
• Bergmann MW, Betts TR, Sievert H, et al. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. Euro Intervention. 2017;13:e877–e884.
   Google Scholar
• Saw J, Nielsen-Kudsk JE, Bergmann M, et al. Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure. JACC Cardiovasc Interv. 2019;12:e1067–e1076. doi:10.1016/j.jcin.2018.11.001
   PubMed Web of Science ®Google Scholar
• Garot P, Cormier B, Horvilleur J. Device-Related Thrombus After Left Atrial Appendage Closure. Interv Cardiol. 2019;14(1):e42–e44. doi:10.15420/icr.2018.21.3
   PubMedGoogle Scholar
• Lehto J, Gunn J, Karjalainen P, et al. Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: the Finland postpericardiotomy syndrome study. J Thorac Cardiovasc Surg. 2015;149(5):e1324–e1329. doi:10.1016/j.jtcvs.2015.01.031
   PubMed Web of Science ®Google Scholar